Jean-Luc C. Mougeot

Dr. Jean-Luc C. Mougeot

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2011 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
JMJean-Luc C. Mougeot
Jean-Luc C. Mougeot
ZLZhen Li
Zhen Li
APAndrea E Price
Andrea E Price
FWFred Wright
Fred Wright
BBBenjamin R Brooks
Benjamin R Brooks
Sporadic amyotrophic lateral sclerosis (sALS) is a motor neuron disease with poorly understood etiology. Results of gene expression profiling studies of whole blood from ALS patients have not been validated and are difficult to relate to ALS pathogenesis because gene expression profiles depend on the relative abundance of the different cell types present in whole blood. We conducted microarray analyses using Agilent Human Whole Genome 4 × 44k Arrays on a more homogeneous cell population, namely purified peripheral blood lymphocytes (PBLs), from ALS patients and healthy controls to identify molecular signatures possibly relevant to ALS pathogenesis.

19 April 2018 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
JMJean-Luc C. Mougeot
Jean-Luc C. Mougeot
BNBraxton Noll
Braxton Noll
FMFarah K. Bahrani Mougeot
Farah K. Bahrani Mougeot

1 January 2016 in Journal of Oral Microbiology
Verified
Journal Article
Open access
PDF file
JMJean-Luc C. Mougeot
Jean-Luc C. Mougeot
CSCraig B. Stevens
Craig B. Stevens
SCSean L. Cotton
Sean L. Cotton
DMDarla S. Morton
Darla S. Morton
KKKeerthana Krishnan
Keerthana Krishnan
FMFarah K. Bahrani Mougeot
Farah K. Bahrani Mougeot
Concordance of HOMIM and HOMI N GS technologies in the microbiome analysis of clinical samples

17 December 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JMJean-Luc C. Mougeot
Jean-Luc C. Mougeot
MBMicaela Beckman
Micaela Beckman
HLHolden C. Langdon
Holden C. Langdon
MBMichael T. Brennan
Michael T. Brennan
FMFarah Bahrani Mougeot
Farah Bahrani Mougeot
The endogenous microbiome of healthy individuals in oral cavities is diverse, representing over 700 bacterial species. Imbalance in oral and gut microbiome composition and associated gene expression has been linked to different forms of hematological (blood) cancers. Our objective is to compare oral microbiome profiles of patients with blood cancers (BC group: N = 39 patients, n = 124 oral samples) to those of healthy control subjects (HC group: N = 27 subjects, n = 100 oral samples). Saliva samples and swabs of buccal mucosa, supragingival plaque, and tongue were collected from blood cancer patients and healthy controls. Next-generation sequencing (16S-rRNA gene V3–V4 region) was used to determine the relative abundance of bacterial taxa present at the genus and species levels. Differences in oral microbiome beta-diversity were determined using multivariate permutational analysis of variance (PERMANOVA). Linear discriminant analysis (LDA) effect size (LEfSe) analysis was performed to identify differentiating bacterial taxa in pairwise comparisons. The PATRICv3.6.7 online tool was used to determine the predominance of potential pathogenicity in the BC group. The oral microbiome beta-diversities of the BC and HC groups differed and corresponded to a reduced alpha-diversity in the BC group. LEfSe analysis showed significant LDA scores for Actinomyces and Rothia spp., differentiating the BC group from the HC group. In silico analysis using PATRICv3.6.7 demonstrated that the groups of bacteria possessing traits of “antibiotic resistance”, “oral pathogen”, and “virulence” was enriched in the BC group. Although 56% of the BC patients received antibiotics within two weeks of the oral bacterial sampling, Actinomyces genus remained the top differentiating feature in the BC group regardless of the administration of antibiotics, while Rothia dentocariosa was detected as the top differentiating feature in the BC patients who did not receive antibiotics, but not in those who received antibiotics. Further investigation is needed to better understand the interactions of certain oral species with the host immune system to better characterize clinically relevant associations with hematological cancers.

1 March 2008 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
RHRichelle A. Hemendinger
Richelle A. Hemendinger
EAEdward J. Armstrong
Edward J. Armstrong
RPRafal Persinski
Rafal Persinski
JTJulianne Todd
Julianne Todd
JMJean-Luc C. Mougeot
Jean-Luc C. Mougeot
JPJeffrey Rosenfeld PhD
Jeffrey Rosenfeld PhD

23 February 2018 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
JKJon Kirk
Jon Kirk
NSNirav Shah
Nirav Shah
BNBraxton Noll
Braxton Noll
CSCraig B. Stevens
Craig B. Stevens
MLMarshall Lawler
Marshall Lawler
JMJean-Luc C. Mougeot
Jean-Luc C. Mougeot